Bibliothek

feed icon rss

Ihre E-Mail wurde erfolgreich gesendet. Bitte prüfen Sie Ihren Maileingang.

Leider ist ein Fehler beim E-Mail-Versand aufgetreten. Bitte versuchen Sie es erneut.

Vorgang fortführen?

Exportieren
  • 1
    Digitale Medien
    Digitale Medien
    Springer
    Journal of radiosurgery 2 (1999), S. 119-125 
    ISSN: 1573-8752
    Schlagwort(e): Radiosurgery ; malignant glioma ; surgery ; brachytherapy
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract The inability to control malignant glioma results in a high incidence of local failure and poor survival. Focal therapy such as radiosurgery permits delivery of a high dose of radiation with moderate toxicity. This report summarizes the outcome of patients with recurrent malignant glioma treated with radiosurgery at University of Wisconsin Hospital, between January 1989 and December 1997, when 30 patients were treated radiosurgically. All patients had undergone and failed external beam radiotherapy (median dose of 59.4 Gy) prior to radiosurgery. All recurrences were detected by clinical deterioration and confirmed by radiographic progression. No patient was treated for radiographic progression only in the context of a screening protocol. Eight out of 30 patients underwent subtotal resection prior to radiosurgery and 3 received chemotherapy along with radiosurgery. Radiosurgery was delivered in a single fraction using a modified linear accelerator. The median tumor volume was 7.2 cm3 (range 0.42–35.1 cm3) and the median minimal tumor dose was 12 Gy at the 50–80% isodose line. Median follow-up is 70 months. The median overall survival is 8 months; the 1- and 2-year survival rates are 20% and 9%, respectively. For patients with an initial diagnosis of non-glioblastoma, the median survival is 11 months and for those with glioblastoma the median survival is 7 months. The median progression-free survival is 4 months for the entire cohort, 5 months for nonglioblastoma, and 3 months for glioblastoma. The 1-year actuarial reoperation rate after radio-surgery is 7.6%. Radiosurgery for recurrent malignant glioma may improve short-term survival for selected patients with a lower reoperation rate than brachytherapy.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
  • 2
    ISSN: 1573-8752
    Schlagwort(e): Brain metastases ; glioblastoma multiforme ; bidimensional product ; tridimensional product ; volume
    Quelle: Springer Online Journal Archives 1860-2000
    Thema: Medizin
    Notizen: Abstract The primary objective of this study is to determine whether the conventionally utilized “gold standard” methodology of bidimensional product is reproducible for the purpose of ascertaining response to treatment in CNS neoplasms. Secondary objectives include testing of volumetric methods for response analysis and examining the variability due to tumor pathology, observer, and other factors. Twenty-five patients with brain metastases (evaluated by serial CT) and 16 patients with glioblastoma multiforme (evaluated by serial MRI) were the subjects of this study. The images were reviewed independently by 5 observers and analyzed subjectively, bidimensionally, tridimensionally, and volumetrically, using an NIH-developed software tool, NIH Image. Volume proved to be the most precise measurement technique. Interobserver reproducibility for volume measurements was superior to that of all other methods tested, with the range of correlation coefficients being: bidimensional product = .88–.98, area = .94–.99, tridimensional product = .75–.99, and volume = .96–1.00. Misclassification in tumor response rates was lowest for volume measurements (mean = .23, range = .20–.27) and highest for bidimensional product (mean = .39, range = .34–.44). Volume derived from CT or MRI is a more precise measure of tumor size, yielding consistently lower misclassification rates than traditional bidimensional product or cross-sectional area. This superiority holds irrespective of pathology, tumor size, or observer.
    Materialart: Digitale Medien
    Bibliothek Standort Signatur Band/Heft/Jahr Verfügbarkeit
    BibTip Andere fanden auch interessant ...
Schließen ⊗
Diese Webseite nutzt Cookies und das Analyse-Tool Matomo. Weitere Informationen finden Sie hier...